ACRO Releases New Report on the Past, Present, and Future of Risk-Based Monitoring Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial quality. To better understand implementation across the industry, the Association of Clinical Research Organizations (ACRO) conducted a landscape survey of RBM implementation across 6,513 clinical trials that were ongoing in 2019 and compiled the information in a comprehensive report. After an unprecedented year, the clinical research industry has proved innovative, even in difficult circumstances. ACRO's latest report highlights a significant shift to risk-based monitoring, titled Risk-based Monitoring in Clinical Trials: Past, Present Future." It also supports the industry shift towards a more holistic Risk Based Quality Management (RBQM) system.